Skip to main content
University of California San Francisco
UCSF School of Medicine
|
Department of Medicine
UCSF Medical Center
Search
Search
Main navigation
About Us
Message from the Chiefs
History
Campuses
Faculty
Staff
Women in Pulmonary
For Patients
Clinic Locations
Asthma
Bronchiectasis & Pulmonary Nontuberculous Mycobacterium
COPD / Emphysema
Cystic Fibrosis
Cystic Fibrosis Clinical Trials
Environmental & Occupational Lung Disease
Global Lung Health / Tuberculosis
Interstitial Lung Disease (ILD)
Lung Cancer and Bronchoscopy
Lung Transplant
Pulmonary Function Testing
Pulmonary Rehabilitation
Sarcoidosis
Sleep Disorders
Research
COVID-19
COMET Study
Basic Biology
Airway/Allergy/ Environmental Disease
Human Exposure Laboratory
Critical Care/Lung Injury
Infection/Global Health
Interstitial Lung Disease
ILD Clinical Trials
Lung Transplantation
Lung Cancer
Sleep
Programs
Nina Ireland Program for Lung Health
Innovative Grants Program
Accomplishment
Contact Us
Fellowship
Pulmonary & Critical Care Medicine Fellowship Program
How to Apply
Clinical Training
Research Training
Research Opportunity
Research Support
Coaching Program
Coaching Program
Fellowship Experience
Living in San Francisco
Diversity
Fellows
COVID-19
Interventional Pulmonary Fellowship Program
Allergy & Immunology Fellowship Program
Giving
Designating Your Gift
Why the Urgency?
Why UCSF?
Breadcrumb
Home
IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
JAMA
2021
https://researcherprofiles.org/profile/212336920
34228779
Matthay MA, Luetkemeyer AF
